Dr. Marshall Nash, MD
Claim this profileNeuroStudies
Studies Alzheimer's Disease
Studies Dystonia
12 reported clinical trials
15 drugs studied
Affiliated Hospitals
Clinical Trials Marshall Nash, MD is currently running
Mevidalen
for Alzheimer's Disease
The main purpose of this study is to look at how safe the study drug (mevidalen) is and whether it works to alleviate symptoms when given to people with mild to moderate Alzheimer Disease (AD) dementia. This is done by looking at participants: thinking and memory (cognition), everyday activities and sleep, AD symptoms, physical activity, irritability or anxiety. The study is expected to last approximately 26 weeks and may include up to 14 visits.
Recruiting0 awards Phase 21 criteria
AR1001
for Alzheimer's Disease
This trial tests AR1001, a medicine for early Alzheimer's Disease. It focuses on people in the early stages of Alzheimer's, aiming to improve their condition through multiple mechanisms.
Recruiting1 award Phase 36 criteria
More about Marshall Nash, MD
Clinical Trial Related2 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Marshall Nash, MD has experience with
- Placebo
- ABP-450
- ABNCoV2
- Comirnaty
- Simufilam
- ATH-1017
Breakdown of trials Marshall Nash, MD has run
Alzheimer's Disease
Dystonia
Focal Dystonias
Wryneck
Torticollis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Marshall Nash, MD specialize in?
Is Marshall Nash, MD currently recruiting for clinical trials?
Are there any treatments that Marshall Nash, MD has studied deeply?
What is the best way to schedule an appointment with Marshall Nash, MD?
What is the office address of Marshall Nash, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.